Medline Reports Mixed Q2 2026 Results: Strong Sales Growth Offset by Fire-Related Losses
Event summary
- Medline reported Q2 2026 net sales of $7.7 billion, up 11.6% YoY.
- Net income fell 58.3% to $139 million due to a $336 million fire-related loss at its Tracy distribution center.
- Adjusted EBITDA increased 13.4% to $1.1 billion, benefiting from IEEPA tariff refunds.
- Full-year organic sales guidance raised to 9.0%-10.0%, while Adjusted EBITDA guidance lowered to $3.3B-$3.4B due to inflation and operational investments.
The big picture
Medline's Q2 results highlight the tension between robust top-line growth and significant operational challenges, including a major facility fire and inflationary pressures from geopolitical conflicts. The company's ability to navigate these issues will be critical as it seeks to maintain its position as the largest provider of medical-surgical products and supply chain solutions.
What we're watching
- Operational Recovery
- The pace at which Medline can recover from the Tracy facility fire and mitigate future disruptions.
- Cost Management
- Whether Medline can sustain profitability amid higher inflationary pressures and operational investments.
- Regulatory Tailwinds
- How the U.S. Supreme Court's IEEPA tariff ruling will continue to impact Medline's financials.
Related topics